首页 > 最新文献

SAGE Open Medical Case Reports最新文献

英文 中文
Uncommon presentation of a chronic recurrent symptomatic encapsulated calcified postoperative paraspinal lumbar hematoma: A case report. 术后腰椎旁血肿慢性复发的罕见表现:一例报告。
IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-09 eCollection Date: 2025-01-01 DOI: 10.1177/2050313X241306892
Timothy Edwards, Shaan Sadhwani, Brendan Sweeney, Antonio Almeda-Lopez, Walter C Peppelman, William J Beutler

Paraspinal hematomas are common complications following spine surgery. In general, these hematomas are asymptomatic and resolve without issue. Unfortunately, there is a paucity of literature that describes the recurrence of these hematomas in a chronic setting. This case report describes a patient with a chronic recurrent calcified paraspinal hematoma that first developed over 4 years and then reoccurred 11 years later at the same site. The case features a 53-year-old female presented with severe lumbar back pain and right lower extremity radiculopathy in which she underwent a lumbar decompression posterior spinal fusion from L3 to L5 in 2008. Postoperatively, she developed a lumbar paraspinal hematoma which was treated with aspiration followed by conservative management. Four years later, the patient had a large paraspinal mass removed from a similar location in an outside medical facility. The procedure required the assistance of plastic surgery for flap closure and a pathologic review of the mass revealed a calcified hematoma. Ten years later, the patient sought treatment from her index surgeon for a recurrence of the lumbar mass with new onset radicular symptoms. Magnetic resonance imaging of the lumbar spine confirmed the presence of a large paraspinal mass. The patient proceeded with the removal of hardware, revision of laminectomy, revision of posterior instrumentation from L2 to L5, and removal of the lumbar mass. The pathology report classified the mass as a chronic calcified hematoma. The patient remains symptom-free for 1 year following the revision procedure. This case demonstrates an extremely rare presentation, ill-described in the existing literature, of a recurrent symptomatic calcified lumbar paraspinal hematoma requiring repeat operative intervention.

脊柱旁血肿是脊柱手术后常见的并发症。一般情况下,这些血肿是无症状的,不会出现问题。不幸的是,缺乏文献描述这些血肿在慢性环境中的复发。本病例报告描述了一个慢性复发的钙化棘旁血肿患者,首次发展超过4年,然后11年后在同一部位再次发生。该病例的特征是一名53岁女性,表现为严重的腰背痛和右下肢神经根病,她于2008年接受了L3至L5腰椎减压后路脊柱融合术。术后,患者出现腰椎棘旁血肿,经抽吸治疗,后行保守治疗。四年后,患者在外部医疗机构的类似位置切除了一个大的椎旁肿块。手术过程中需要整形手术的帮助皮瓣关闭和病理检查肿块显示钙化血肿。十年后,患者因腰椎肿块复发并出现新发神经根性症状而向她的主治医生寻求治疗。腰椎的磁共振成像证实存在一个大的椎旁肿块。患者进行了硬体取出,椎板切除术翻修,后路内固定从L2到L5翻修,腰椎肿块切除。病理报告将肿块分类为慢性钙化血肿。患者在翻修手术后1年无症状。本病例是一个非常罕见的病例,在现有文献中描述不清,复发性症状钙化腰椎棘旁血肿需要重复手术干预。
{"title":"Uncommon presentation of a chronic recurrent symptomatic encapsulated calcified postoperative paraspinal lumbar hematoma: A case report.","authors":"Timothy Edwards, Shaan Sadhwani, Brendan Sweeney, Antonio Almeda-Lopez, Walter C Peppelman, William J Beutler","doi":"10.1177/2050313X241306892","DOIUrl":"10.1177/2050313X241306892","url":null,"abstract":"<p><p>Paraspinal hematomas are common complications following spine surgery. In general, these hematomas are asymptomatic and resolve without issue. Unfortunately, there is a paucity of literature that describes the recurrence of these hematomas in a chronic setting. This case report describes a patient with a chronic recurrent calcified paraspinal hematoma that first developed over 4 years and then reoccurred 11 years later at the same site. The case features a 53-year-old female presented with severe lumbar back pain and right lower extremity radiculopathy in which she underwent a lumbar decompression posterior spinal fusion from L3 to L5 in 2008. Postoperatively, she developed a lumbar paraspinal hematoma which was treated with aspiration followed by conservative management. Four years later, the patient had a large paraspinal mass removed from a similar location in an outside medical facility. The procedure required the assistance of plastic surgery for flap closure and a pathologic review of the mass revealed a calcified hematoma. Ten years later, the patient sought treatment from her index surgeon for a recurrence of the lumbar mass with new onset radicular symptoms. Magnetic resonance imaging of the lumbar spine confirmed the presence of a large paraspinal mass. The patient proceeded with the removal of hardware, revision of laminectomy, revision of posterior instrumentation from L2 to L5, and removal of the lumbar mass. The pathology report classified the mass as a chronic calcified hematoma. The patient remains symptom-free for 1 year following the revision procedure. This case demonstrates an extremely rare presentation, ill-described in the existing literature, of a recurrent symptomatic calcified lumbar paraspinal hematoma requiring repeat operative intervention.</p>","PeriodicalId":21418,"journal":{"name":"SAGE Open Medical Case Reports","volume":"13 ","pages":"2050313X241306892"},"PeriodicalIF":0.6,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11719446/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142971992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Window decompression surgery for a large radicular cyst in a 7-year-old patient: A case report. 窗减压术治疗7岁大神经根囊肿1例。
IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-08 eCollection Date: 2025-01-01 DOI: 10.1177/2050313X241313086
Guan-Jie Song, Lu Wang, Li-Rong Gao

Radicular cysts are rarely present in the primary dentition because of the distinct biological cycle of primary teeth. Cyst formation in children may cause bony expansion and resorption, malposition, delayed eruption, enamel defects, or damage to the developing permanent successors. Various treatment modalities for the management of radicular cysts have been reported in the literature. In this case, the preferred treatment approach is window decompression surgery (WDS) combined with gap retainers. Long-term follow-up revealed good healing of the bony lesion. The present case involved an abnormally large radicular cyst in a 7-year-old girl. After surgery, WDS was performed, and a gap retainer was provided. At the 9-month follow-up, the radicular cyst had healed and the impacted tooth had erupted. The aim of this study was to explore the clinical effectiveness of WDS for impacted teeth within root radicular cysts.

根状囊肿很少出现在初级牙列,因为初级牙的独特的生物周期。儿童囊肿形成可引起骨扩张和骨吸收、错位、延迟出疹、牙釉质缺损或对发育中的永久继位者造成损害。各种治疗方式的根性囊肿的管理已在文献中报道。在这种情况下,首选的治疗方法是窗减压手术(WDS)联合间隙固位器。长期随访显示骨性病变愈合良好。本病例涉及一个异常大的神经根囊肿在一个7岁的女孩。术后行WDS,提供间隙固位器。在9个月的随访中,根状囊肿愈合,阻生牙爆发。本研究的目的是探讨WDS治疗牙根根囊肿埋伏牙的临床效果。
{"title":"Window decompression surgery for a large radicular cyst in a 7-year-old patient: A case report.","authors":"Guan-Jie Song, Lu Wang, Li-Rong Gao","doi":"10.1177/2050313X241313086","DOIUrl":"https://doi.org/10.1177/2050313X241313086","url":null,"abstract":"<p><p>Radicular cysts are rarely present in the primary dentition because of the distinct biological cycle of primary teeth. Cyst formation in children may cause bony expansion and resorption, malposition, delayed eruption, enamel defects, or damage to the developing permanent successors. Various treatment modalities for the management of radicular cysts have been reported in the literature. In this case, the preferred treatment approach is window decompression surgery (WDS) combined with gap retainers. Long-term follow-up revealed good healing of the bony lesion. The present case involved an abnormally large radicular cyst in a 7-year-old girl. After surgery, WDS was performed, and a gap retainer was provided. At the 9-month follow-up, the radicular cyst had healed and the impacted tooth had erupted. The aim of this study was to explore the clinical effectiveness of WDS for impacted teeth within root radicular cysts.</p>","PeriodicalId":21418,"journal":{"name":"SAGE Open Medical Case Reports","volume":"13 ","pages":"2050313X241313086"},"PeriodicalIF":0.6,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707760/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142954256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cutaneous pseudolymphoma successfully treated with intralesional triamcinolone acetonide: A case report. 局部曲安奈德治疗皮肤假性淋巴瘤1例。
IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-08 eCollection Date: 2025-01-01 DOI: 10.1177/2050313X241311362
Nicole Asamoah, Lara Gunton

Cutaneous pseudolymphoma refers to a group of skin conditions that simulate lymphoma either clinically and/or histologically. Cutaneous pseudolymphoma is a benign disorder that can often be misdiagnosed and has a wide range of treatment modalities. Currently, there is no gold standard of treatment, and the literature would benefit from more reports on successful and unsuccessful treatments of cutaneous pseudolymphoma. In this case, we present a 24-year-old female with cutaneous pseudolymphoma successfully treated with intralesional triamcinolone acetonide after misdiagnosis and several failures with other treatments.

皮肤假性淋巴瘤是指一组皮肤状况,无论是临床和/或组织学模拟淋巴瘤。皮肤假性淋巴瘤是一种经常被误诊的良性疾病,有广泛的治疗方式。目前还没有治疗的金标准,更多关于皮肤假性淋巴瘤成功和不成功治疗的报道将使文献受益。在这个病例中,我们报告了一位24岁的女性皮肤假性淋巴瘤,在误诊和多次其他治疗失败后,经局灶内曲安奈德治疗成功。
{"title":"Cutaneous pseudolymphoma successfully treated with intralesional triamcinolone acetonide: A case report.","authors":"Nicole Asamoah, Lara Gunton","doi":"10.1177/2050313X241311362","DOIUrl":"https://doi.org/10.1177/2050313X241311362","url":null,"abstract":"<p><p>Cutaneous pseudolymphoma refers to a group of skin conditions that simulate lymphoma either clinically and/or histologically. Cutaneous pseudolymphoma is a benign disorder that can often be misdiagnosed and has a wide range of treatment modalities. Currently, there is no gold standard of treatment, and the literature would benefit from more reports on successful and unsuccessful treatments of cutaneous pseudolymphoma. In this case, we present a 24-year-old female with cutaneous pseudolymphoma successfully treated with intralesional triamcinolone acetonide after misdiagnosis and several failures with other treatments.</p>","PeriodicalId":21418,"journal":{"name":"SAGE Open Medical Case Reports","volume":"13 ","pages":"2050313X241311362"},"PeriodicalIF":0.6,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707766/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142954246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of pityriasis rubra pilaris secondary to ponatinib. 波纳替尼继发的毛疹糠疹1例。
IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-08 eCollection Date: 2025-01-01 DOI: 10.1177/2050313X241311341
Ariana Nateghi, Florence Lagacé-Thomassin, Julie Desrochers

Ponatinib, a tyrosine kinase inhibitor used for chronic myeloid leukemia and acute lymphoblastic leukemia, can cause rare cutaneous side effects. In this case, a 63-year-old woman developed a pityriasis rubra pilaris-like eruption 1 month after starting the drug. The skin reaction improved with dose reduction and recurred more mildly at a lower dose. Symptomatic relief was achieved with topical tretinoin, triamcinolone, and emollients. This case underscores the importance of managing dose-dependent skin reactions while maintaining cancer therapy.

Ponatinib是一种酪氨酸激酶抑制剂,用于治疗慢性髓性白血病和急性淋巴细胞白血病,可引起罕见的皮肤副作用。在这个病例中,一名63岁的女性在开始用药1个月后出现了红斑糠疹样的疹。皮肤反应随剂量减少而改善,低剂量时复发较轻。局部使用维甲酸、曲安奈德和润肤剂可以缓解症状。这个病例强调了在维持癌症治疗的同时管理剂量依赖性皮肤反应的重要性。
{"title":"A case of pityriasis rubra pilaris secondary to ponatinib.","authors":"Ariana Nateghi, Florence Lagacé-Thomassin, Julie Desrochers","doi":"10.1177/2050313X241311341","DOIUrl":"https://doi.org/10.1177/2050313X241311341","url":null,"abstract":"<p><p>Ponatinib, a tyrosine kinase inhibitor used for chronic myeloid leukemia and acute lymphoblastic leukemia, can cause rare cutaneous side effects. In this case, a 63-year-old woman developed a pityriasis rubra pilaris-like eruption 1 month after starting the drug. The skin reaction improved with dose reduction and recurred more mildly at a lower dose. Symptomatic relief was achieved with topical tretinoin, triamcinolone, and emollients. This case underscores the importance of managing dose-dependent skin reactions while maintaining cancer therapy.</p>","PeriodicalId":21418,"journal":{"name":"SAGE Open Medical Case Reports","volume":"13 ","pages":"2050313X241311341"},"PeriodicalIF":0.6,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707771/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142954245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dental implant in esthetic zone: A case report. 美观区种植牙1例。
IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-08 eCollection Date: 2025-01-01 DOI: 10.1177/2050313X241311702
Jarupat Jundaeng, Rapeeporn Chamchong, Choosak Nithikathkul

This case report emphasizes the complexities involved in dental implant placement within the anterior esthetic zone, focusing on the integration of advanced surgical techniques and meticulous prosthetic design for optimal esthetic and functional results. A 28-year-old male presented with the absence of the upper left central incisor, which had been extracted 5 years prior due to fracture. Clinical and radiographic assessments indicated normal alveolar bone levels; however, the esthetic demands required a specialized approach. The surgical procedure included a papilla preservation flap, immediate implant placement, and bone grafting to prevent peri-implant resorption and achieve an optimal emergence profile. An Osstem implant and resorbable Xenograft were utilized to address the thin labial bone. Over 4 months, successful osseointegration occurred, followed by the placement of a permanent crown. This case illustrates that dental implant restoration in the anterior esthetic zone can effectively address functional and esthetic challenges, leading to high patient satisfaction with the final restoration's natural appearance.

本病例报告强调了牙种植体在前美学区植入的复杂性,重点是将先进的外科技术和细致的假体设计相结合,以获得最佳的美学和功能效果。一名28岁男性,因骨折5年前拔除左上中切牙缺失。临床和影像学检查显示牙槽骨水平正常;然而,审美需求需要一个专门的方法。手术过程包括乳头保存瓣、即刻种植体放置和植骨,以防止种植体周围的吸收并达到最佳的出现轮廓。系统种植体和可吸收的异种移植物被用于解决唇骨薄。4个多月后,成功实现骨融合,随后放置永久冠。本病例说明,在前美学区种植体修复可以有效地解决功能和美学方面的挑战,导致患者对最终修复的自然外观有很高的满意度。
{"title":"Dental implant in esthetic zone: A case report.","authors":"Jarupat Jundaeng, Rapeeporn Chamchong, Choosak Nithikathkul","doi":"10.1177/2050313X241311702","DOIUrl":"https://doi.org/10.1177/2050313X241311702","url":null,"abstract":"<p><p>This case report emphasizes the complexities involved in dental implant placement within the anterior esthetic zone, focusing on the integration of advanced surgical techniques and meticulous prosthetic design for optimal esthetic and functional results. A 28-year-old male presented with the absence of the upper left central incisor, which had been extracted 5 years prior due to fracture. Clinical and radiographic assessments indicated normal alveolar bone levels; however, the esthetic demands required a specialized approach. The surgical procedure included a papilla preservation flap, immediate implant placement, and bone grafting to prevent peri-implant resorption and achieve an optimal emergence profile. An Osstem implant and resorbable Xenograft were utilized to address the thin labial bone. Over 4 months, successful osseointegration occurred, followed by the placement of a permanent crown. This case illustrates that dental implant restoration in the anterior esthetic zone can effectively address functional and esthetic challenges, leading to high patient satisfaction with the final restoration's natural appearance.</p>","PeriodicalId":21418,"journal":{"name":"SAGE Open Medical Case Reports","volume":"13 ","pages":"2050313X241311702"},"PeriodicalIF":0.6,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707788/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142954247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genital porokeratosis: A case report and review of pathogenesis and genitogluteal subtypes of porokeratosis. 生殖器角化症:一例报告和审查的发病机制和生殖器麸质亚型的角化症。
IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-08 eCollection Date: 2025-01-01 DOI: 10.1177/2050313X241311369
Camille Hamm, Jennifer Lipson

Porokeratosis is a condition characterized by abnormal epidermal keratinization with a unique morphology of papules or plaques surrounded by a thread-like border of scale corresponding to the cornoid lamella on histology. Many established subtypes have been described; however, genitogluteal porokeratosis is a rare entity. We present the case of a 58-year-old male with pruritic reddish lesions affecting the genitals and thighs, diagnosed with genital porokeratosis. This case highlights features of this rare and diagnostically challenging subtype of porokeratosis.

角化孔症是一种以异常表皮角化为特征的疾病,其独特的形态为丘疹或斑块,周围有线状的鳞屑边界,在组织学上与角膜片状相对应。已经描述了许多已确定的亚型;然而,外阴葡孔角化症是一种罕见的疾病。我们提出的情况下,58岁的男性瘙痒红色病变影响生殖器和大腿,诊断为生殖器孔角化症。本病例突出了这种罕见且诊断上具有挑战性的多孔角化症亚型的特征。
{"title":"Genital porokeratosis: A case report and review of pathogenesis and genitogluteal subtypes of porokeratosis.","authors":"Camille Hamm, Jennifer Lipson","doi":"10.1177/2050313X241311369","DOIUrl":"https://doi.org/10.1177/2050313X241311369","url":null,"abstract":"<p><p>Porokeratosis is a condition characterized by abnormal epidermal keratinization with a unique morphology of papules or plaques surrounded by a thread-like border of scale corresponding to the cornoid lamella on histology. Many established subtypes have been described; however, genitogluteal porokeratosis is a rare entity. We present the case of a 58-year-old male with pruritic reddish lesions affecting the genitals and thighs, diagnosed with genital porokeratosis. This case highlights features of this rare and diagnostically challenging subtype of porokeratosis.</p>","PeriodicalId":21418,"journal":{"name":"SAGE Open Medical Case Reports","volume":"13 ","pages":"2050313X241311369"},"PeriodicalIF":0.6,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707782/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142954249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe atopic dermatitis treated with Dupilumab in a CTLA-4-deficient patient: A case report and review of the literature. 用Dupilumab治疗ctla -4缺陷患者的严重特应性皮炎:一个病例报告和文献回顾。
IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-07 eCollection Date: 2025-01-01 DOI: 10.1177/2050313X241311042
Ye-Jean Park, Jennifer Grossman, Lynne Robertson

Atopic dermatitis is a chronic inflammatory skin disease associated with immune dysregulation, particularly overexpression of T helper 2 cytokines. Cytotoxic T lymphocyte-associated antigen 4 deficiency, a primary immune disorder, can exacerbate atopic dermatitis. Dupilumab, an IL-4 and IL-13 receptor antagonist, has demonstrated efficacy in controlling severe, recalcitrant atopic dermatitis by mitigating T helper 2-driven inflammation. We present a case of a 24-year-old male with cytotoxic T lymphocyte-associated antigen 4 haploinsufficiency and severe atopic dermatitis successfully managed with Dupilumab. The patient showed marked improvement in eczema severity scores, including a sixfold reduction in the Eczema Area and Severity Index and a threefold reduction in the Dermatology Life Quality Index over 6 months, highlighting Dupilumab's potential role in cytotoxic T lymphocyte-associated antigen 4-deficient patients experiencing atopic dermatitis.

特应性皮炎是一种慢性炎症性皮肤病,与免疫失调有关,特别是辅助性T - 2细胞因子的过度表达。细胞毒性T淋巴细胞相关抗原4缺乏症是一种原发性免疫疾病,可加重特应性皮炎。Dupilumab是一种IL-4和IL-13受体拮抗剂,已经证明可以通过减轻T辅助2驱动的炎症来控制严重的难治性特应性皮炎。我们报告了一例24岁的男性与细胞毒性T淋巴细胞相关抗原4单倍功能不全和严重的特应性皮炎成功地管理杜匹单抗。患者湿疹严重程度评分明显改善,包括湿疹面积和严重程度指数降低6倍,皮肤病生活质量指数在6个月内降低3倍,突出了Dupilumab在细胞毒性T淋巴细胞相关抗原4缺陷患者经历特应性皮炎中的潜在作用。
{"title":"Severe atopic dermatitis treated with Dupilumab in a CTLA-4-deficient patient: A case report and review of the literature.","authors":"Ye-Jean Park, Jennifer Grossman, Lynne Robertson","doi":"10.1177/2050313X241311042","DOIUrl":"https://doi.org/10.1177/2050313X241311042","url":null,"abstract":"<p><p>Atopic dermatitis is a chronic inflammatory skin disease associated with immune dysregulation, particularly overexpression of T helper 2 cytokines. Cytotoxic T lymphocyte-associated antigen 4 deficiency, a primary immune disorder, can exacerbate atopic dermatitis. Dupilumab, an IL-4 and IL-13 receptor antagonist, has demonstrated efficacy in controlling severe, recalcitrant atopic dermatitis by mitigating T helper 2-driven inflammation. We present a case of a 24-year-old male with cytotoxic T lymphocyte-associated antigen 4 haploinsufficiency and severe atopic dermatitis successfully managed with Dupilumab. The patient showed marked improvement in eczema severity scores, including a sixfold reduction in the Eczema Area and Severity Index and a threefold reduction in the Dermatology Life Quality Index over 6 months, highlighting Dupilumab's potential role in cytotoxic T lymphocyte-associated antigen 4-deficient patients experiencing atopic dermatitis.</p>","PeriodicalId":21418,"journal":{"name":"SAGE Open Medical Case Reports","volume":"13 ","pages":"2050313X241311042"},"PeriodicalIF":0.6,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11705363/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142954251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-fatal acute barium carbonate poisoning following suicidal ingestion: A case report. 自杀性摄入非致命性急性碳酸钡中毒1例。
IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-04 eCollection Date: 2025-01-01 DOI: 10.1177/2050313X241311316
Waiian Leong, Chunlian Li, Yuhui Long, Yanli Wang, Abraham Kc Wai, Yi Huang, Feilung Lau

Acute barium poisoning is a rare but life-threatening method of suicide attempt, and it is a challenging disease in the emergency department. We report a case of barium carbonate poisoning in a 21-year-old man who ingested a large dose to attempt suicide and presented with gastrointestinal symptoms, gradual muscular weakness, and severe hypokalemia (K+1.63 mmol/L). He was promptly managed with gastric lavage, respiratory support, and large doses of oral and intravenous potassium supplementation. In addition, intravenous sodium thiosulfate and continuous venovenous hemodiafiltration were administered to reduce the serum concentration of barium ions. Following comprehensive treatment, the patient recovered within 5 days and discharged home for 12 days. Clinicians should be vigilant when a patient presents gastrointestinal symptoms and limb weakness, associated with severe hypokalemia and cardiac arrhythmia over a short disease course as these may indicate potential barium poisoning. Furthermore, we advocate for paying more attention to the management of toxic substances and the mental health education of young adults.

急性钡中毒是一种罕见但危及生命的自杀未遂手段,在急诊科是一种具有挑战性的疾病。我们报告了一例碳酸钡中毒病例,患者是一名 21 岁的男性,为自杀未遂摄入了大量碳酸钡,并出现了胃肠道症状、渐进性肌肉无力和严重的低钾血症(K+1.63 mmol/L)。医生迅速对他进行了洗胃、呼吸支持以及大剂量口服和静脉补钾治疗。此外,还进行了静脉注射硫代硫酸钠和持续静脉血液透析,以降低血清中的钡离子浓度。经过综合治疗,患者在 5 天内痊愈,12 天后出院回家。当患者在短期内出现胃肠道症状和四肢无力,并伴有严重的低钾血症和心律失常时,临床医生应提高警惕,因为这可能预示着潜在的钡中毒。此外,我们提倡更加关注有毒物质的管理和青壮年的心理健康教育。
{"title":"Non-fatal acute barium carbonate poisoning following suicidal ingestion: A case report.","authors":"Waiian Leong, Chunlian Li, Yuhui Long, Yanli Wang, Abraham Kc Wai, Yi Huang, Feilung Lau","doi":"10.1177/2050313X241311316","DOIUrl":"https://doi.org/10.1177/2050313X241311316","url":null,"abstract":"<p><p>Acute barium poisoning is a rare but life-threatening method of suicide attempt, and it is a challenging disease in the emergency department. We report a case of barium carbonate poisoning in a 21-year-old man who ingested a large dose to attempt suicide and presented with gastrointestinal symptoms, gradual muscular weakness, and severe hypokalemia (K<sup>+</sup>1.63 mmol/L). He was promptly managed with gastric lavage, respiratory support, and large doses of oral and intravenous potassium supplementation. In addition, intravenous sodium thiosulfate and continuous venovenous hemodiafiltration were administered to reduce the serum concentration of barium ions. Following comprehensive treatment, the patient recovered within 5 days and discharged home for 12 days. Clinicians should be vigilant when a patient presents gastrointestinal symptoms and limb weakness, associated with severe hypokalemia and cardiac arrhythmia over a short disease course as these may indicate potential barium poisoning. Furthermore, we advocate for paying more attention to the management of toxic substances and the mental health education of young adults.</p>","PeriodicalId":21418,"journal":{"name":"SAGE Open Medical Case Reports","volume":"13 ","pages":"2050313X241311316"},"PeriodicalIF":0.6,"publicationDate":"2025-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11700400/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142932557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cyclosporine-induced thrombotic microangiopathy in pregnant women: A case report and literature review. 孕妇环孢素诱发的血栓性微血管病1例报告并文献复习。
IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-04 eCollection Date: 2025-01-01 DOI: 10.1177/2050313X241308693
Su Zhang, Hai-Hui Zhou, Zi-Xing Zhong, Qi-Qi Wang, Ping Huang, Su-Xiao Liu

Cyclosporine A (CsA) is a commonly used immunosuppressant, but its association with thrombotic microangiopathy (TMA) is rarely reported. In recent years, CsA has been used in pregnant women with autoimmune diseases or previous immune-related adverse pregnancies. Our case involves a 34-year-old female who developed typical laboratory indicators of TMA while using CsA to improve pregnancy outcomes. After discontinuing CsA, the TMA markers gradually normalized. To our knowledge, this is the first report of CsA-induced TMA during pregnancy. We also reviewed previous case reports of CsA-induced TMA and summarized the possible mechanisms, characteristics, and risk factors, as well as methods to identify this rare adverse effect of CsA in pregnant women.

环孢素 A(CsA)是一种常用的免疫抑制剂,但其与血栓性微血管病(TMA)相关的报道却很少。近年来,CsA 被用于患有自身免疫性疾病或曾有过免疫相关不良妊娠史的孕妇。我们的病例涉及一名 34 岁女性,她在使用 CsA 改善妊娠结局时出现了典型的 TMA 实验室指标。停用 CsA 后,TMA 指标逐渐恢复正常。据我们所知,这是第一例妊娠期 CsA 引起 TMA 的报告。我们还回顾了之前关于 CsA 诱导的 TMA 的病例报告,总结了可能的机制、特征和风险因素,以及鉴别这种罕见的孕妇 CsA 不良反应的方法。
{"title":"Cyclosporine-induced thrombotic microangiopathy in pregnant women: A case report and literature review.","authors":"Su Zhang, Hai-Hui Zhou, Zi-Xing Zhong, Qi-Qi Wang, Ping Huang, Su-Xiao Liu","doi":"10.1177/2050313X241308693","DOIUrl":"https://doi.org/10.1177/2050313X241308693","url":null,"abstract":"<p><p>Cyclosporine A (CsA) is a commonly used immunosuppressant, but its association with thrombotic microangiopathy (TMA) is rarely reported. In recent years, CsA has been used in pregnant women with autoimmune diseases or previous immune-related adverse pregnancies. Our case involves a 34-year-old female who developed typical laboratory indicators of TMA while using CsA to improve pregnancy outcomes. After discontinuing CsA, the TMA markers gradually normalized. To our knowledge, this is the first report of CsA-induced TMA during pregnancy. We also reviewed previous case reports of CsA-induced TMA and summarized the possible mechanisms, characteristics, and risk factors, as well as methods to identify this rare adverse effect of CsA in pregnant women.</p>","PeriodicalId":21418,"journal":{"name":"SAGE Open Medical Case Reports","volume":"13 ","pages":"2050313X241308693"},"PeriodicalIF":0.6,"publicationDate":"2025-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11700391/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142932556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of discoid lupus erythematosus scarring alopecia with deucravacitinib: A case report. 地克拉伐替尼治疗盘状红斑狼疮瘢痕性脱发1例。
IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-02 eCollection Date: 2025-01-01 DOI: 10.1177/2050313X241304891
Katherine Aw, Genevieve Gavigan

Discoid lupus erythematosus is a chronic, recurring, autoimmune skin disease causing annular, scarring plaques on the head and neck. Deucravacitinib, a tyrosine kinase 2 inhibitor in the Janus kinase inhibitor family, represents an emerging treatment option in systemic lupus erythematosus with potential applicability to discoid lupus erythematosus. We describe a 48-year-old woman with multiple treatment-refractory scalp plaques and associated alopecia treated with deucravacitinib. She demonstrated resolution of symptoms and 1-2 cm hair regrowth at a 3-month follow-up, with significant hair regrowth and reduction in plaque size at a 6-month follow-up. The patient tolerated the medication well with no side effects. This case highlights the potential of deucravacitinib as an effective therapy for refractory discoid lupus erythematosus.

盘状红斑狼疮是一种慢性、复发性自身免疫性皮肤病,会在头颈部形成环状瘢痕斑块。Deucravacitinib是Janus激酶抑制剂家族中的一种酪氨酸激酶2抑制剂,是治疗系统性红斑狼疮的一种新兴疗法,有可能适用于盘状红斑狼疮。我们描述了一名 48 岁的女性患者,她患有多发性治疗难治性头皮斑块和相关脱发,接受了 deucravacitinib 治疗。在 3 个月的随访中,她的症状得到缓解,头发重新生长了 1-2 厘米,在 6 个月的随访中,头发明显重新生长,斑块面积缩小。患者对药物的耐受性良好,没有任何副作用。本病例凸显了deucravacitinib作为一种有效疗法治疗难治性盘状红斑狼疮的潜力。
{"title":"Treatment of discoid lupus erythematosus scarring alopecia with deucravacitinib: A case report.","authors":"Katherine Aw, Genevieve Gavigan","doi":"10.1177/2050313X241304891","DOIUrl":"https://doi.org/10.1177/2050313X241304891","url":null,"abstract":"<p><p>Discoid lupus erythematosus is a chronic, recurring, autoimmune skin disease causing annular, scarring plaques on the head and neck. Deucravacitinib, a tyrosine kinase 2 inhibitor in the Janus kinase inhibitor family, represents an emerging treatment option in systemic lupus erythematosus with potential applicability to discoid lupus erythematosus. We describe a 48-year-old woman with multiple treatment-refractory scalp plaques and associated alopecia treated with deucravacitinib. She demonstrated resolution of symptoms and 1-2 cm hair regrowth at a 3-month follow-up, with significant hair regrowth and reduction in plaque size at a 6-month follow-up. The patient tolerated the medication well with no side effects. This case highlights the potential of deucravacitinib as an effective therapy for refractory discoid lupus erythematosus.</p>","PeriodicalId":21418,"journal":{"name":"SAGE Open Medical Case Reports","volume":"13 ","pages":"2050313X241304891"},"PeriodicalIF":0.6,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11694284/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142932560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
SAGE Open Medical Case Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1